Market LIVE
Published markets; coverage varies by country
Product profile · United States

OZEMPIC

 ·  Patent Litigation & Settlement History ↓

IngredientSEMAGLUTIDE
Application typeNDA
Application209637
Product001
Dosage formSOLUTION
RouteSUBCUTANEOUS
Strength2MG/1.5ML (1.34MG/ML)
Approval date2017-12-05
Marketing statusDISCONTINUED
Status event—
ApplicantNOVO
Product source

Current GenericRadar decision

Year2025
SelectionDISQUALIFIED
ReviewFINAL
Anchor typeFDA_DISCONTINUATION
Anchor date—
Patent anchor2031-12-05
Exclusivity anchor2022-12-05
Protection date2033-06-21
First Final ANDA—
Status event—

GNR judgment: DISQUALIFIED. Reference year: 2025. Anchor type: FDA_DISCONTINUATION. Patent anchor: 2031-12-05. Exclusivity anchor: 2022-12-05. Anchor date: not recorded. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
103576162026-01-20DP —NNDP
English description not available.
———
103576162026-01-20ORANGE_BOOK —NNDP
English description not available.
———
103766522026-01-20DP —NNDP
English description not available.
———
103766522026-01-20ORANGE_BOOK —NNDP
English description not available.
———
91080022026-01-20DP —NNDP
English description not available.
———
91080022026-01-20ORANGE_BOOK —NNDP
English description not available.
———
96161802026-01-20DP —NNDP
English description not available.
———
96161802026-01-20ORANGE_BOOK —NNDP
English description not available.
———
98617572026-01-20DP —NNDP
English description not available.
———
98617572026-01-20ORANGE_BOOK —NNDP
English description not available.
———
85361222026-03-20DS/DP/U U-2202YNTRUE_DS
English description not available.
———
85361222026-03-20ORANGE_BOOK U-2202YNTRUE_DS
English description not available.
———
102201552026-07-17DP —NNDP
English description not available.
———
102201552026-07-17ORANGE_BOOK —NNDP
English description not available.
———
110970632026-07-17DP —NNDP
English description not available.
———
110970632026-07-17ORANGE_BOOK —NNDP
English description not available.
———
89203832026-07-17DP —NNDP
English description not available.
———
89203832026-07-17ORANGE_BOOK —NNDP
English description not available.
———
97759532026-07-17DP —NNDP
English description not available.
———
97759532026-07-17ORANGE_BOOK —NNDP
English description not available.
———
RE463632026-08-03DP —NNDP
English description not available.
———
RE463632026-08-03ORANGE_BOOK —NNDP
English description not available.
———
96876112027-02-27DP —NNDP
English description not available.
———
96876112027-02-27ORANGE_BOOK —NNDP
English description not available.
———
94571542027-09-29DP —NNDP
English description not available.
———
94571542027-09-29ORANGE_BOOK —NNDP
English description not available.
———
81293432031-12-05DS/DP/U U-2202YNTRUE_DS
English description not available.
———
81293432031-12-05ORANGE_BOOK U-2202YNTRUE_DS
English description not available.
———
91322392032-02-01DP —NNDP
English description not available.
———
91322392032-02-01ORANGE_BOOK —NNDP
English description not available.
———
103354622033-06-21U U-2580NNU
English description not available.
———
103354622033-06-21ORANGE_BOOK U-2580NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2017-12-052022-12-05English description not available.YY2022-12-05
NCE
Full coverage date: 2022-12-05
Source
I-8222020-01-162023-01-16English description not available.NN—
NCE
Full coverage date: —
Source
I-9612025-01-282028-01-28English description not available.NN——Source
I-9612025-01-282028-01-28English description not available.NN—
NCE
Full coverage date: —
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (20)
TypeDateRoleBasisSource
PATENT2026-01-20HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2026-01-20HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2026-01-20HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2026-01-20HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2026-01-20HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2026-03-20HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2026-07-17HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2026-07-17HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2026-07-17HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2026-07-17HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2026-08-03HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2027-02-27HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2027-09-29HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2031-12-05HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2032-02-01HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-06-21HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_STATUS—TERMINAL_STATUSEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.